Last Friday we noted that a new paper by Vickers et al. has formally recommended that PSA velocity be removed from guidelines on the use of diagnostic data to decide whether a man should have a biopsy to assess his potential risk for prostate cancer. We expressed no opinion on the article at that time … READ MORE …
Filed under: Diagnosis, Risk | Tagged: best practice, biopsy, guideline, PSA, velocity | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site